Mahnia Madan, OD, FAAO

Mahnia Madan, OD, FAAO

Dr. Mahnia Madan is a graduate of Pacific University College of Optometry and did a residency in ocular disease and surgical co-management at the Eye Center of Texas in Houston. Dr. Madan is a fellow of the American Academy of Optometry and has lectured on the management of ocular diseases including dry eyes and glaucoma. She practices in Vancouver, BC where she splits her time between an ophthalmology and an optometry practice. Her practice focuses on the use of innovative treatments for advanced dry eye disease such as Platelet Rich Plasma (PRP) and Intense Pulse Light (IPL). She and her team developed the technique to make PRP eye drops in her Vancouver clinic. She also currently serves as Vice President for the BC Doctors of Optometry in BC.

4

Resources
Incorporating In-Office Dry Eye Treatments When At-Home Care Isn't Enough
General
Incorporating In-Office Dry Eye Treatments When At-Home Care Isn't Enough

At-home care combined with in-office treatments leads to much better results for patients than either one alone. Learn about the latest in-office options for dry eye disease.

March 22, 2022
What Doctors Think About the New Generic of Restasis
Pharmaceuticals
What Doctors Think About the New Generic of Restasis

Restasis has been a go-to eye drop for dry eye disease for two decades. We interviewed four optometrists to see how they felt about the newly FDA-approved generic version of cyclosporine ophthalmic emulsion 0.05%, and this what they had to say.

February 25, 2022
The Dry Eye Content You Missed at Eyes On 2022
Dry Eye
The Dry Eye Content You Missed at Eyes On 2022

Missed Eyes On 2022? This largest virtual event of the year for ECPs featured some incredible sessions from leaders in the field of dry eye. Access on-demand recordings now.

February 4, 2022
Using Platelet-Rich Plasma Eye Drops In Dry Eye Therapy
Dry Eye
Using Platelet-Rich Plasma Eye Drops In Dry Eye Therapy

Lubricating eye drops are common first-line therapies for dry eye, but no drops truly replicate the biochemistry of natural tears. Platelet rich plasma (PRP) could change all that.

July 28, 2021